4.1 Article

An analysis of monocytes and dendritic cells differentiated from human peripheral blood monocyte-derived induced pluripotent stem cells

期刊

MEDICAL MOLECULAR MORPHOLOGY
卷 53, 期 2, 页码 63-72

出版社

SPRINGER JAPAN KK
DOI: 10.1007/s00795-019-00231-8

关键词

Human peripheral monocyte; Monocyte-derived iPS cells; Dendritic cells; Differentiation; Phagocytosis; HLA-DR

资金

  1. MEXT/JSPS KAKENHI [JP17K09677, JP17K11495, 18K15935]
  2. Grants-in-Aid for Scientific Research [18K15935] Funding Source: KAKEN

向作者/读者索取更多资源

Dendritic cell-based immunotherapy, which uses a patient's own immune cells, can be used for cancer treatment and allergy control, such as autoimmune disease and rejection associated with transplantation. However, these treatments create a burden on patients due to repeated blood collection. We used cell biological analysis of monocytes with few mutations obtained from minimal blood collection for genome recombination. Next, we established human peripheral blood monocyte-derived induced pluripotent stem cells (iPSCs) using a commercial vector and standard culture method. We found that when established iPSCs were induced to differentiate, monocytes showed phagocytic properties and expressed CD14 and CX3CR1. Further, the generated dendritic cells (DCs) expressed CCL17 and highly expressed HLA-DR following the addition of the mite antigen. Taken together, these data show that monocyte-derived iPS cells can be used to differentiate into monocytes and DCs. In addition, the use of these cells can be applied to the pathological analysis of dendritic cell therapy and monocyte diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据